ATE216998T1 - Camptothecin-derivate mit antitumor-wirkung - Google Patents

Camptothecin-derivate mit antitumor-wirkung

Info

Publication number
ATE216998T1
ATE216998T1 AT99830124T AT99830124T ATE216998T1 AT E216998 T1 ATE216998 T1 AT E216998T1 AT 99830124 T AT99830124 T AT 99830124T AT 99830124 T AT99830124 T AT 99830124T AT E216998 T1 ATE216998 T1 AT E216998T1
Authority
AT
Austria
Prior art keywords
tumor effect
camptothecin derivatives
camptothecin
derivatives
tumor
Prior art date
Application number
AT99830124T
Other languages
English (en)
Inventor
Sergio Penco
Lucio Merlini
Paolo Carminati
Franco Zunino
Original Assignee
Sigma Tau Ind Farmaceuti
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti, Ist Naz Stud Cura Dei Tumori filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE216998T1 publication Critical patent/ATE216998T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT99830124T 1999-03-09 1999-03-09 Camptothecin-derivate mit antitumor-wirkung ATE216998T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99830124A EP1044977B1 (de) 1999-03-09 1999-03-09 Camptothecin-Derivate mit Antitumor-Wirkung

Publications (1)

Publication Number Publication Date
ATE216998T1 true ATE216998T1 (de) 2002-05-15

Family

ID=8243303

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99830124T ATE216998T1 (de) 1999-03-09 1999-03-09 Camptothecin-derivate mit antitumor-wirkung

Country Status (38)

Country Link
US (2) US6242457B1 (de)
EP (1) EP1044977B1 (de)
JP (1) JP4610743B2 (de)
KR (1) KR100702085B1 (de)
CN (1) CN1139592C (de)
AR (1) AR022860A1 (de)
AT (1) ATE216998T1 (de)
AU (1) AU774174B2 (de)
BG (1) BG65032B1 (de)
BR (1) BR0008840B1 (de)
CA (1) CA2362760C (de)
CO (1) CO5180590A1 (de)
CZ (1) CZ304465B6 (de)
DE (1) DE69901379T2 (de)
DK (1) DK1044977T3 (de)
EA (1) EA003605B1 (de)
EE (1) EE04679B1 (de)
EG (1) EG23999A (de)
ES (1) ES2175919T3 (de)
HR (1) HRP20010667B1 (de)
HU (1) HU229506B1 (de)
IL (2) IL144958A0 (de)
IS (1) IS2003B (de)
ME (2) MEP4008A (de)
MX (1) MXPA01009081A (de)
NO (1) NO328363B1 (de)
NZ (1) NZ513393A (de)
PE (1) PE20001485A1 (de)
PL (1) PL222208B1 (de)
PT (1) PT1044977E (de)
RS (1) RS50405B (de)
SI (1) SI1044977T1 (de)
SK (1) SK287561B6 (de)
TN (1) TNSN00045A1 (de)
TR (1) TR200102603T2 (de)
TW (1) TWI272272B (de)
WO (1) WO2000053607A1 (de)
ZA (1) ZA200107408B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ512676A (en) 1999-01-13 2003-01-31 Meditech Res Ltd A composition and method for the enhancement of the efficacy of drugs
US7105492B2 (en) 1999-03-09 2006-09-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity
FR2794123B1 (fr) * 1999-05-28 2001-07-27 Aventis Pharma Sa Preparation de derives de la camptothecine et de la nothapodytine
US6352996B1 (en) * 1999-08-03 2002-03-05 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
US9066919B2 (en) * 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
AUPQ879500A0 (en) * 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
US20040029906A1 (en) * 2001-07-31 2004-02-12 Michael Christman Inhibitors of dna polymerase sigma
JP2005505540A (ja) * 2001-08-27 2005-02-24 メディテック　リサーチ　リミテッド 改善された治療プロトコール
WO2003033525A1 (en) * 2001-10-12 2003-04-24 Debio Recherche Pharmacuetique S.A. Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament
ITRM20020305A1 (it) * 2002-05-31 2003-12-01 Sigma Tau Ind Farmaceuti Camptotecine con anello lattonico modificato.
ITRM20020306A1 (it) * 2002-05-31 2003-12-01 Sigma Tau Ind Farmaceuti Esteri in posizione 20 di camptotecine.
FR2852606A1 (fr) * 2003-03-18 2004-09-24 Inst Nat Sante Rech Med Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie
US20040204435A1 (en) * 2003-04-09 2004-10-14 Joachim Liehr Alternating treatment with topoisomerase I and topoisomerase II inhibitors
ITRM20030344A1 (it) 2003-07-14 2005-01-15 Ist Naz Stud Cura Dei Tumori 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi.
CA2559532A1 (en) * 2004-03-26 2005-10-06 Novartis Ag Use of camptothecin derivates for the treatment of proliferative diseases in a fixed dosing regimen
AU2005244768B2 (en) 2004-04-27 2011-06-09 Wellstat Biologics Corporation Cancer treatment using viruses and camptothecins
ITRM20040241A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 20 con antagonisti delle integrine.
ITRM20040240A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
ITRM20040242A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.
ITRM20040288A1 (it) * 2004-06-11 2004-09-11 Sigma Tau Ind Farmaceuti Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.
CN100334089C (zh) * 2004-07-21 2007-08-29 王洋 一种9－硝基喜树碱的生产方法
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
JP5345323B2 (ja) * 2004-12-15 2013-11-20 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ 癌を処置するための治療剤の組合せ
US7799921B2 (en) 2004-12-21 2010-09-21 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Stereoselective process and crystalline forms of a camptothecin
SA06270147B1 (ar) 2005-06-09 2009-12-22 نوفارتيس ايه جي عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين
AU2006270297B2 (en) 2005-07-14 2013-01-17 Wellstat Biologics Corporation Cancer treatment using viruses, fluoropyrimidines and camptothecins
CN101287474B (zh) * 2005-07-27 2014-08-20 阿尔卡米亚肿瘤学股份有限公司 使用乙酰透明质酸的治疗方案
ITRM20050418A1 (it) * 2005-08-04 2007-02-05 Sigma Tau Ind Farmaceuti Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina.
WO2007017513A2 (en) * 2005-08-10 2007-02-15 Novartis Ag Formulations for 7-(t-butoxy)iminomethyl camptothecin
MY149606A (en) * 2005-09-07 2013-09-13 Alchemia Oncology Pty Ltd Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
RS52272B (sr) * 2005-12-21 2012-10-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Lečenje tumora otpornih na lek
EP1989212B1 (de) * 2006-02-17 2013-06-19 Cascade Prodrug Inc. Behandlung hyperproliferativer erkrankungen mit vincaalkaloid-n-oxid und analoga
EP1998809B1 (de) 2006-03-30 2014-06-25 Drais Pharmaceuticals, Inc. Konjugate von camptothecin und zelldurchdringenden peptiden und deren pharmazeutische zusammensetzungen.
AU2008210511A1 (en) * 2007-02-01 2008-08-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Pharmaceutical composition comprising a campothecin derivative
WO2008098701A1 (en) * 2007-02-13 2008-08-21 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives
JP5765937B2 (ja) * 2007-08-01 2015-08-19 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ 小児腫瘍の治療
EP2096113A1 (de) * 2008-02-05 2009-09-02 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. 9-substituierte Camptothecin-Derivate als Antitumorverbindungen
TWI482621B (zh) 2009-12-23 2015-05-01 Sigma Tau Ind Farmaceuti 青蒿素基藥物與其他化學治療劑的抗癌組合物
WO2017053920A1 (en) 2015-09-25 2017-03-30 Zy Therapeutics Inc. Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
WO2025252101A1 (zh) * 2024-06-05 2025-12-11 荣昌生物制药(烟台)股份有限公司 一种喜树碱类化合物及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399276A (en) * 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
NZ245112A (en) * 1991-11-15 1995-07-26 Smithkline Beecham Corp Pharmaceutical composition comprising a camptothecin analog and a platinum coordination compound
US5614529A (en) * 1994-09-22 1997-03-25 Research Triangle Institute Inhibition of plasmodia parasites by camptothecin compounds
US5972955A (en) * 1995-06-06 1999-10-26 Dr. Reddy's Research Foundation Water soluble C-ring analogues of 20(S)-camptothecin
GB9512670D0 (en) * 1995-06-21 1995-08-23 Sod Conseils Rech Applic Camptothecin analogues
IT1282673B1 (it) * 1996-02-23 1998-03-31 Ist Naz Stud Cura Dei Tumori Derivati della camptotecina e loro uso come agenti antitumorali
DE69728152T2 (de) * 1996-08-19 2004-08-05 Bionumerik Pharmaceuticals, Inc., San Antonio Hoch-lipophile campothecin-derivate

Also Published As

Publication number Publication date
KR100702085B1 (ko) 2007-04-02
AR022860A1 (es) 2002-09-04
KR20010102519A (ko) 2001-11-15
IS2003B (is) 2005-04-15
CZ304465B6 (cs) 2014-05-21
AU3160400A (en) 2000-09-28
CA2362760C (en) 2009-08-18
NZ513393A (en) 2003-04-29
IS6031A (is) 2001-07-31
CN1139592C (zh) 2004-02-25
NO20014128L (no) 2001-08-24
CZ20013077A3 (cs) 2002-01-16
IL144958A0 (en) 2002-06-30
CO5180590A1 (es) 2002-07-30
YU64301A (sh) 2005-07-19
JP2002539128A (ja) 2002-11-19
ZA200107408B (en) 2002-05-29
BG105810A (en) 2002-06-28
ES2175919T3 (es) 2002-11-16
DE69901379T2 (de) 2002-11-07
MXPA01009081A (es) 2002-08-30
HRP20010667A2 (en) 2002-08-31
MEP4008A (xx) 2010-02-10
NO328363B1 (no) 2010-02-01
PT1044977E (pt) 2002-09-30
TR200102603T2 (tr) 2002-01-21
US6242457B1 (en) 2001-06-05
BR0008840A (pt) 2002-01-08
EE200100466A (et) 2002-12-16
PL222208B1 (pl) 2016-07-29
EP1044977A1 (de) 2000-10-18
ME00017B (me) 2010-06-10
BR0008840B1 (pt) 2011-12-27
DK1044977T3 (da) 2002-07-08
HU229506B1 (en) 2014-01-28
NO20014128D0 (no) 2001-08-24
EA200100954A1 (ru) 2002-04-25
EG23999A (en) 2008-03-19
SK11642001A3 (sk) 2002-01-07
HRP20010667B1 (en) 2003-06-30
JP4610743B2 (ja) 2011-01-12
DE69901379D1 (de) 2002-06-06
PE20001485A1 (es) 2000-12-07
SK287561B6 (sk) 2011-02-04
US20010008939A1 (en) 2001-07-19
CA2362760A1 (en) 2000-09-14
EE04679B1 (et) 2006-08-15
SI1044977T1 (en) 2002-08-31
IL144958A (en) 2009-08-03
TWI272272B (en) 2007-02-01
EP1044977B1 (de) 2002-05-02
US6589939B2 (en) 2003-07-08
RS50405B (sr) 2009-12-31
TNSN00045A1 (fr) 2005-11-10
HK1031222A1 (en) 2001-06-08
HUP0200210A2 (hu) 2002-05-29
CN1343209A (zh) 2002-04-03
EA003605B1 (ru) 2003-06-26
PL355094A1 (en) 2004-03-22
AU774174B2 (en) 2004-06-17
WO2000053607A1 (en) 2000-09-14
HUP0200210A3 (en) 2004-03-29
BG65032B1 (bg) 2006-12-29

Similar Documents

Publication Publication Date Title
ATE216998T1 (de) Camptothecin-derivate mit antitumor-wirkung
ATE304352T1 (de) Indolyl-3-glyoxylsäure-derivate mit antitumorwirkung
IS2116B (is) 4-fenyl-pyridin afleiður
NO20021077L (no) Amino-triazolopyridin-derivater
ATE263748T1 (de) Admantan-derivate
ATE293104T1 (de) Thiazolylamid-derivate
EE200100613A (et) 13-metüülerütromütsiini derivaadid
NO20015701L (no) 5-Fenyl-pyrimidin-derivater
NO20021803D0 (no) Isoksazolkarboksamid-derivater
DK1240157T3 (da) Substituerede N-benzyl-indol-3-yl-glyoxylsyrederivater med antitumorvirkning
ATE257148T1 (de) Propargyletherderivate
ATE374747T1 (de) Monofluoralkylderivate
ATE273272T1 (de) Mevinolinderivate
ATE293592T1 (de) Resorcinderivate
DK1187815T3 (da) 4-phenyl-pyrimidinderivater
ATE254598T1 (de) 4-hydroxybiphenylhydrazid-derivate
NO20005031D0 (no) Kinolin-4-yl-derivater II
NO20004892D0 (no) Kinolin-4-yl-derivater I
DE50015441D1 (de) Fadenliefergerät mit verstellbarer fadenleiteinrichtung
DE60025348D1 (de) Ethansulfonyl-piperidin-derivate
DK1088818T3 (da) Quinolin-4-yl-derivater
NO20020212D0 (no) 3-amino-2-benzyl-1-fenyl-propanderivater
DK1178984T3 (da) 1-trifluormethyl-4-hydroxy-7-piperidinylaminomethylchroman-derivater
DE59909774D1 (de) 1-cycloalkylpyrazolyl-benzoyl-derivate
ATE259816T1 (de) Tricyclische benzoylcyclohexandion-derivate